High-risk multiple myeloma vs standard-risk myeloma: what’s the difference? (In a minute or less)

Q&A | Hope for High-Risk Multiple Myeloma: Latest Treatments & Life Expectancy Insights

What is HRMM (High-Risk Multiple Myeloma)? #myeloma

High-Risk vs. Standard-Risk Multiple Myeloma: What Patients Need to Know in 1 Minute

High-risk multiple myeloma: addressing challenges and unmet needs

How is high-risk multiple myeloma determined? #HRMM #cytogenetics

How long can high-risk multiple myeloma patients survive without treatment?

What does it mean to have functional high-risk multiple myeloma?

FAQs on High-Risk Disease

What’s the next step for a high-risk multiple myeloma patient with heart failure?

Identifying high-risk multiple myeloma patient subgroups using genetic and clinical factors

My Self Advocacy Journey with Ultra High-Risk Multiple Myeloma

What Causes Smoldering Myeloma and Who is at High Risk?

Defining High Risk Multiple Myeloma | Wee Joo Chng, MD, PhD | IMS 2024

CAR T-cell therapy for high-risk multiple myeloma

Treating High Risk Multiple Myeloma an Evidence-Based Approach | Katja Weisel, MD | IMS 2024

Approaching and managing relapsed high-risk myeloma

New Standard of Care for High-Risk Smoldering Multiple Myeloma: Insights from ASH 2024

High-risk myeloma makes up about 20% of cases and tends to be more aggressive and return faster

Case 2: Overcoming High Risk in Myeloma